SUBSCRIBE
SUBSCRIBE

Phase 3

Drug Development
Clinical Trial Abused for Profits
October 5, 2007
 · 
1 min read
Drug Development
UT Southwestern Medical Center Investigating Hypothermic Technique in Treating Pediatric Head Injuries
October 3, 2007
 · 
1 min read
Drug Development
Clinical Trials for Diabetes Drugs Should Measure Outcomes Important to Patients, States Mayo Clinic Researchers in The Lancet
October 2, 2007
 · 
1 min read
Drug Development
Drug Study Seeks Those with Advanced Skin Cancer
October 1, 2007
 · 
1 min read
Drug Development
U.S. Report Faults FDA Oversight of Drug Trials
September 28, 2007
 · 
1 min read
Drug Development
Clinical Trials Directive Still Hampering Academic Medical Research
September 27, 2007
 · 
1 min read
Drug Development
Vanderbilt University Awarded $40 Million for Clinical and Translational Research
September 21, 2007
 · 
1 min read
Drug Development
Novel Program Underway to Increase Participation in Clinical Trials-a Critical Step in Development of Improved Medical Therapies
September 21, 2007
 · 
1 min read
Drug Development
Opening up the Findings of Drug Trials
September 17, 2007
 · 
1 min read
Drug Development
Clinical Trials Present Better Alternatives for Dialysis Patients
September 12, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 26, 2026
 · 
15 min read
Press Releases
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
February 26, 2026
 · 
7 min read
Press Releases
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
February 26, 2026
 · 
3 min read
Press Releases
Sarepta Therapeutics to Present New Long-Term and Safety Data Across Gene Therapy and Exon-Skipping Programs at 2026 Muscular Dystrophy Association Clinical & Scientific Congress
February 26, 2026
 · 
6 min read
Press Releases
Tris Pharma to Present Debut Data from Phase 3 ALLEVIATE 1-2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting
February 26, 2026
 · 
4 min read
Press Releases
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
February 26, 2026
 · 
7 min read
Press Releases
Lilly’s oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet
February 26, 2026
 · 
10 min read
Press Releases
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
February 26, 2026
 · 
13 min read
Press Releases
InnoCare Announces Key Developments of Critical Clinical Studies
February 26, 2026
 · 
3 min read
Press Releases
MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001
February 26, 2026
 · 
3 min read
Press Releases
Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026
February 26, 2026
 · 
19 min read
Press Releases
Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1
February 26, 2026
 · 
6 min read
Press Releases
ITM to Announce Phase 3 COMPETE Trial Post-Hoc Subgroup Analysis in Pancreatic Neuroendocrine Tumors and Host Satellite Symposium at ENETS 2026
February 25, 2026
 · 
3 min read
Press Releases
Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria
February 25, 2026
 · 
7 min read
Press Releases
Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
February 25, 2026
 · 
5 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
February 24, 2026
 · 
19 min read
Press Releases
Abcuro Announces Topline Results from the MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis
February 24, 2026
 · 
3 min read
Press Releases
Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference
February 24, 2026
 · 
7 min read
Press Releases
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
February 24, 2026
 · 
11 min read
Press Releases
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
February 24, 2026
 · 
5 min read
Load More